title: Tacrolimus and posttransplant diabetes mellitus in renal transplantation.
abstract: The most prominent side effect of tacrolimus is the induction of posttransplant diabetes mellitus (PTDM). In this review, the authors discuss the incidence, mechanism, prevention, and treatment of tacrolimus-induced PTDM in renal patients.
authors.affiliation: Department of Internal Medicine, University Hospital Maastricht, NL-6202 AZ Maastricht, The Netherlands. jho@sint.azm.nl
authors.forename: Johannes P
authors.initials: JP
authors.lastname: van Hooff
authors.forename: Maarten H L
authors.initials: MH
authors.lastname: Christiaans
authors.forename: Elly M
authors.initials: EM
authors.lastname: van Duijnhoven
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000276:immunology; D011183:Postoperative Complications / Q000139:chemically induced*; D012307:Risk Factors; D016559:Tacrolimus / Q000037:antagonists & inhibitors*
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus